Maccura Biotechnology Co.Ltd (SHE:300463)
China flag China · Delayed Price · Currency is CNY
9.45
+0.03 (0.32%)
Aug 11, 2026, 3:04 PM CST

SHE:300463 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
769.18667.19671.45835.96587.35637.16
Trading Asset Securities
45.1150.1860.06311.14663.72-
Cash & Short-Term Investments
814.29717.36731.521,1471,251637.16
Cash Growth
14.66%-1.93%-36.23%-8.31%96.35%4.10%
Accounts Receivable
1,0761,1541,5891,8342,1361,924
Other Receivables
47.77103.0923.327.6519.4121.61
Receivables
1,1241,2571,6131,8612,1551,946
Inventory
845.14849.13901.58907.491,0391,076
Other Current Assets
340.15404.09393.84306.33251.87195.77
Total Current Assets
3,1243,2283,6404,2224,6983,855
Property, Plant & Equipment
3,7303,8123,4072,9292,5132,015
Long-Term Investments
141.92145.68173.93172.73193.81144.12
Goodwill
51.0451.0451.04145.15145.1521.32
Other Intangible Assets
406.51402.1375.16283.25269.37194.61
Long-Term Deferred Tax Assets
175.57158.86133.78153.86161.45161.18
Long-Term Deferred Charges
114.29119.2119.6142.4113.4295.51
Other Long-Term Assets
75.1777.5975.7170.1974.4579.77
Total Assets
7,8197,9957,9768,1198,1686,567
Accounts Payable
182.62208.67316.75365.85380.89317.43
Accrued Expenses
58.27102.18136.39136.86152.61131.59
Short-Term Debt
174.03258.96255.1144.65248.08530.56
Current Portion of Long-Term Debt
164.23155.95202.42330.56139.1130
Current Portion of Leases
5.195.198.8614.4813.213.64
Current Income Taxes Payable
1.113.145.6919.3139.8423.6
Current Unearned Revenue
106.67100.1872.0472.3674.4177
Other Current Liabilities
90.24219.1198.7136.5435.2289.35
Total Current Liabilities
782.371,0531,1961,1211,0831,313
Long-Term Debt
592.59521.87184.12162.5285.8424.1
Long-Term Leases
4.894.36.7912.9815.0417.15
Long-Term Unearned Revenue
24.9324.6923.8328.831.0728.1
Long-Term Deferred Tax Liabilities
76.7477.92134179.07223.72242.65
Other Long-Term Liabilities
3.16.757.943.83--
Total Liabilities
1,4851,6891,5531,5081,6392,025
Common Stock
604.67604.67612.47612.47612.47556.47
Additional Paid-In Capital
1,5921,5921,7831,7811,781279.51
Retained Earnings
4,1154,0804,1794,1474,0473,624
Treasury Stock
---220.24-170.18-170.18-170.18
Comprehensive Income & Other
-2.33-1.0714.1814.8923.298.34
Total Common Equity
6,3096,2766,3696,3856,2934,299
Minority Interest
25.3930.0354.61226.64236.25243.16
Shareholders' Equity
6,3346,3066,4246,6116,5294,542
Total Liabilities & Equity
7,8197,9957,9768,1198,1686,567
Total Debt
940.93946.27657.29665.17701.221,115
Net Cash (Debt)
-126.63-228.974.23481.94549.84-478.29
Net Cash Growth
---84.60%-12.35%--
Net Cash Per Share
-0.21-0.380.120.790.90-0.86
Filing Date Shares Outstanding
604.67604.67608.51606.83612.47556.47
Total Common Shares Outstanding
604.67604.67608.51606.83612.47556.47
Working Capital
2,3412,1752,4443,1023,6142,542
Book Value Per Share
10.4310.3810.4710.5210.277.72
Tangible Book Value
5,8515,8235,9435,9565,8794,083
Tangible Book Value Per Share
9.689.639.779.829.607.34
Buildings
1,9021,907783.53783.35739.86732.5
Machinery
2,9062,8682,5082,3041,9931,808
Construction In Progress
243.672211,103714.48504.0176.97